Purine-containing compound catabolic process

pathway activity — cross-omics
GO:0072523Cross-omicsPROTEIN-MS → RNAPatientPairwise association · TCGA cohorts

Across TCGA patient cohorts, RNA activity of the Purine-containing compound catabolic process pathway is significantly associated with the RNA expression of multiple genes, with the GBM cohort showing a particularly strong set of associations.

The most reproducible pathway-associated genes across cancer lineages are ALOX5, KIAA1958, and LST1, each associated with the pathway in up to 7 cancer types. Since the analysis shows associations rather than directional relationships, both pathway-to-partner and partner-to-pathway views are reported.

Each partner is linked to its corresponding Q-omics profile. The scatter plot shows the strongest association, Purine-containing compound catabolic process activity versus ALOX5 in GBM (Pearson r = 0.33).

Pathway-associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (pathway→partner) and Y-score (partner→pathway) are standardized regression coefficients; both directions are reported because the association is undirected. The reported p-values are derived from the association test.
LineagePartner geneX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
GBMALOX5 →+0.809+0.130.002.00137
HNSCKIAA1958 →-0.525-0.158<.001.00336
UCECLST1 →+0.782+0.156.004.00236
LSCCFCGR2A →+0.832+0.225<.001<.00136
HNSCCCR5 →+0.783+0.200.002<.00136
HNSCNEMP1 →-0.630-0.169.001.00135
Each partner links to its Q-omics profile. Showing the 6 strongest associations by consensus.

GO:0072523 vs ALOX5 — GBM

Per-sample scatter of Purine-containing compound catabolic process activity vs ALOX5 in GBM.

Explore this scatter interactively →

Exploration